2020
DOI: 10.1111/cpr.12802
|View full text |Cite
|
Sign up to set email alerts
|

Placental endovascular extravillous trophoblasts (enEVTs) educate maternal T‐cell differentiation along the maternal‐placental circulation

Abstract: Objectives: During human pregnancy, the endothelial cells of the uterine spiral arteries (SPA) are extensively replaced by a subtype of placental trophoblasts, endovascular extravillous trophoblasts (enEVTs), thus establishing a placental-maternal circulation. On this pathway, foetus-derived placental villi and enEVTs bath into the maternal blood that perfuses along SPA being not attacked by the maternal lymphocytes. We aimed to reveal the underlying mechanism of such immune tolerance. Methods:In situ hybridiz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 57 publications
0
12
0
Order By: Relevance
“…Treatment with vasoactive intestinal peptide (VIP) in a miscarriage-prone mouse model (CBA/J×DBA/2) can regulate the endocytosis of maternal macrophages and promote the expression of TGF-b1 at the implantation site of the mouse, significantly increasing the number of implant points (97). In addition, Ma et al (98) found that endovascular extravillous trophoblasts (enEVTs) actively produced TGF-b1, and primary enEVTs promoted the differentiation of naive CD4 + T cells into immunosuppressive Tregs in a TGF-b1-dependent manner. The proportion of TGF-b1-producing enEVTs and their ability to educate Tregs differentiation were significantly reduced in RSA patients.…”
Section: Rsamentioning
confidence: 99%
See 1 more Smart Citation
“…Treatment with vasoactive intestinal peptide (VIP) in a miscarriage-prone mouse model (CBA/J×DBA/2) can regulate the endocytosis of maternal macrophages and promote the expression of TGF-b1 at the implantation site of the mouse, significantly increasing the number of implant points (97). In addition, Ma et al (98) found that endovascular extravillous trophoblasts (enEVTs) actively produced TGF-b1, and primary enEVTs promoted the differentiation of naive CD4 + T cells into immunosuppressive Tregs in a TGF-b1-dependent manner. The proportion of TGF-b1-producing enEVTs and their ability to educate Tregs differentiation were significantly reduced in RSA patients.…”
Section: Rsamentioning
confidence: 99%
“…In addition, Ma et al. ( 98 ) found that endovascular extravillous trophoblasts (enEVTs) actively produced TGF-β1, and primary enEVTs promoted the differentiation of naive CD4 + T cells into immunosuppressive Tregs in a TGF-β1-dependent manner. The proportion of TGF-β1-producing enEVTs and their ability to educate Tregs differentiation were significantly reduced in RSA patients.…”
Section: Tgf-β1 In Pathological Pregnancymentioning
confidence: 99%
“…Similar result was obtained in another experiment that HLA-G + EVTs co-cultured with matched CD4 + T cells led to the augment of CD4 + CD25 HI FOXP3 + CD45RA + resting Treg cells (97). Recently, further research has shown that endovascular extravillous trophoblasts (enEVTs), but not interstitial extravillous trophoblasts (iEVTs), were capable of promoting the differentiation of naïve CD4 + T cells into immunosuppressive Treg cells in a TGF-β1-dependent manner, establishing immune tolerance along the placental-maternal circulation (98). As mentioned earlier, IL-35 is also an important regulator of Treg cell function and differentiation.…”
Section: Crosstalk Between Trophoblasts and The Immune-suppressive Trmentioning
confidence: 99%
“…In addition, Treg differentiation was also achieved by endovascular extravillous trophoblasts (enEVTs), which are capable of establishing placental-maternal circulation during human pregnancy [ 133 ]. However, a recent study observed that a significant decrease in the percentage of enEVTs was associated with the failure of Treg cell differentiation, leading to insufficient spiral artery remodeling in RSA patients [ 134 ].…”
Section: T Cellsmentioning
confidence: 99%